These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4185263)

  • 21. [Distribution of the range of natural sensitivity to antitubercular preparations in cultures of strains of mycobacterum BCG].
    Kulikova MF
    Antibiotiki; 1968 Jul; 13(7):642-7. PubMed ID: 4301383
    [No Abstract]   [Full Text] [Related]  

  • 22. [Heterogeneity of drug-resistant strains of Mycobacterium tuberculosis].
    Belogurova VP
    Probl Tuberk; 1970; 48(9):76-9. PubMed ID: 4996497
    [No Abstract]   [Full Text] [Related]  

  • 23. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
    Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
    Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
    Rudoĭ NM
    Probl Tuberk; 1974; (10):1-6. PubMed ID: 4213757
    [No Abstract]   [Full Text] [Related]  

  • 25. [Interactions of antitubercular drugs. II. Combined effects of rifampin, ethambutol, capreomycin, viomycin, ethionamide and cycloserine on mycobacterial growth in vitro].
    Janowiec M; Zwolska-Kwiek Z
    Pneumonol Pol; 1983 Dec; 51(12):607-12. PubMed ID: 6199778
    [No Abstract]   [Full Text] [Related]  

  • 26. [Incidence of drug sensitivity decrease in tuberculosis bacteria in untreated tuberculoses using autopsy material].
    Schuh D; Justus J; Wichmann G
    Z Erkr Atmungsorgane; 1974 Mar; 140(1):91-8. PubMed ID: 4212675
    [No Abstract]   [Full Text] [Related]  

  • 27. The 7H11 medium for the cultivation of mycobacteria.
    Cohn ML; Waggoner RF; McClatchy JK
    Am Rev Respir Dis; 1968 Aug; 98(2):295-6. PubMed ID: 4299186
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anti-bacterial activity of capreomycin, kanamycin, or viomycin against drug-resistant tubercle bacilli isolated from patients].
    Endo K
    Jpn J Antibiot; 1971 Jun; 24(3):149-51. PubMed ID: 4327336
    [No Abstract]   [Full Text] [Related]  

  • 29. [The experimental studies on antituberculous activity of lividomycin].
    Yamamoto K; Sakurai H; Inoue I; Yamagami K
    Kekkaku; 1972 May; 47(5):135-8. PubMed ID: 4339540
    [No Abstract]   [Full Text] [Related]  

  • 30. The fundamental studies on antituberculous activities of lividomycin.
    Gomi J; Aoyagi T; Torikai K; Yamada Y; Fujino T
    Kekkaku; 1971 Jul; 46(7):265-9. PubMed ID: 4329783
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin].
    Makarevich NM; Mkrtchian SV; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):345-51. PubMed ID: 4321321
    [No Abstract]   [Full Text] [Related]  

  • 32. Cross-resistance relationships between capreomycin, kanamycin, and viomycin resistances in tubecle bacilli from paients.
    Tsukamura M
    Am Rev Respir Dis; 1969 May; 99(5):780-2. PubMed ID: 4306213
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evolution of antibiograms of bacilli persisting under treatment in the sanatorium].
    Marion L
    Rev Tuberc Pneumol (Paris); 1967; 31(6):785-808. PubMed ID: 4317451
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the effect of cycloserine and kanamycin on Mycobacterium tuberculosis (bacteriological and electron microscopic study)].
    Chertkova EI
    Probl Tuberk; 1965; 43(9):57-62. PubMed ID: 4958492
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)].
    Saito T; Fukuhara Y
    Kekkaku; 1974 Mar; 49(3):57-61. PubMed ID: 4136031
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H; Mizuno S; Tsukamura S
    Kekkaku; 1967 Oct; 42(10):399-404. PubMed ID: 4295935
    [No Abstract]   [Full Text] [Related]  

  • 37. [Correlation between the catalase activity and resistance to drugs in Mycobacterium tuberculosis circulating in Southeast Africa].
    Zykov MP
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Mar; 43(3):49-53. PubMed ID: 4295172
    [No Abstract]   [Full Text] [Related]  

  • 38. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on the susceptibility of secondary anti-tuberculosis drugs (with special reference to the resistance-stabilities of cycloserine and ethionamide-resistant bacilli)].
    Hayashi S
    Kumamoto Igakkai Zasshi; 1970 Feb; 44(2):135-43. PubMed ID: 4986047
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of antitubercular preparations on the sub-bacteriostatic action of cycloserine and ethionamide].
    Mkrtchian SV
    Probl Tuberk; 1968; 46(9):62-4. PubMed ID: 5718433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.